DE69917299T2 - Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen - Google Patents

Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen Download PDF

Info

Publication number
DE69917299T2
DE69917299T2 DE69917299T DE69917299T DE69917299T2 DE 69917299 T2 DE69917299 T2 DE 69917299T2 DE 69917299 T DE69917299 T DE 69917299T DE 69917299 T DE69917299 T DE 69917299T DE 69917299 T2 DE69917299 T2 DE 69917299T2
Authority
DE
Germany
Prior art keywords
antibody
eosinophils
basophils
ril
quantification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69917299T
Other languages
German (de)
English (en)
Other versions
DE69917299D1 (de
Inventor
A. Montero Julian Felix
Anne M. Morel Montero
Herve Brailly
Michel Delaage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech SAS filed Critical Immunotech SAS
Publication of DE69917299D1 publication Critical patent/DE69917299D1/de
Application granted granted Critical
Publication of DE69917299T2 publication Critical patent/DE69917299T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Fire-Detection Mechanisms (AREA)
DE69917299T 1998-09-10 1999-09-09 Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen Expired - Lifetime DE69917299T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9811456 1998-09-10
FR9811456A FR2783326B1 (fr) 1998-09-10 1998-09-10 Procede de detection ou de quantification des basophiles et des eosinophiles
PCT/FR1999/002145 WO2000016103A1 (fr) 1998-09-10 1999-09-09 Procede de detection ou de quantification des basophiles et des eosinophiles

Publications (2)

Publication Number Publication Date
DE69917299D1 DE69917299D1 (de) 2004-06-17
DE69917299T2 true DE69917299T2 (de) 2005-05-12

Family

ID=9530419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69917299T Expired - Lifetime DE69917299T2 (de) 1998-09-10 1999-09-09 Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen

Country Status (9)

Country Link
US (1) US7101678B1 (https=)
EP (1) EP1112499B1 (https=)
JP (1) JP2002525580A (https=)
AT (1) ATE266870T1 (https=)
AU (1) AU747648B2 (https=)
CA (1) CA2342738A1 (https=)
DE (1) DE69917299T2 (https=)
FR (1) FR2783326B1 (https=)
WO (1) WO2000016103A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4796443B2 (ja) * 2006-06-08 2011-10-19 シスメックス株式会社 試料分析用試薬、試料分析用試薬キット及び試料分析方法
JP4914656B2 (ja) 2006-06-26 2012-04-11 シスメックス株式会社 試料分析用試薬、試料分析用試薬キット及び試料分析方法
JP2009236798A (ja) * 2008-03-28 2009-10-15 Sysmex Corp 好塩基球の分類計数方法
JP5865009B2 (ja) * 2011-10-25 2016-02-17 シスメックス株式会社 活性化好中球の検出方法
RU2698048C2 (ru) * 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
WO2020028671A1 (en) * 2018-08-03 2020-02-06 Scripps Health Detection and isolation of myeloid-derived suppressor cell subpopulations
CN116577508A (zh) * 2023-03-16 2023-08-11 江苏博华医药科技有限公司 单克隆抗体Ab614荧光复合物及应用
CN116819076A (zh) * 2023-05-26 2023-09-29 首都医科大学附属北京同仁医院 一种预测或评估抗IL-4Rα单抗在治疗慢性鼻窦炎伴鼻息肉中疗效的生物标志物、应用和方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096704A (en) * 1988-11-03 1992-03-17 Schering Corporation Method of treating eosinophilia
JP2900039B2 (ja) * 1989-09-22 1999-06-02 聖志 高津 マウスインターロイキン５レセプターに対する抗体
TW280833B (https=) * 1990-12-27 1996-07-11 Hoffmann La Roche
DE4120213C2 (de) * 1991-06-19 2000-01-05 Boehringer Ingelheim Int Monoklonale Antikörper gegen das TNF-bindende Protein I (TNF-BP I)
US5627040A (en) * 1991-08-28 1997-05-06 Becton Dickinson And Company Flow cytometric method for autoclustering cells
US5776709A (en) * 1991-08-28 1998-07-07 Becton Dickinson And Company Method for preparation and analysis of leukocytes in whole blood
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US6537764B1 (en) * 1995-01-19 2003-03-25 Children's Medical Center Corporation Method of identifying inhibitors of C—C chemokine receptor 3
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
US6599914B2 (en) * 2001-04-24 2003-07-29 Schering Corporation Inhibition of cytokine generation

Also Published As

Publication number Publication date
AU5626799A (en) 2000-04-03
EP1112499A1 (fr) 2001-07-04
ATE266870T1 (de) 2004-05-15
FR2783326B1 (fr) 2000-12-01
US7101678B1 (en) 2006-09-05
EP1112499B1 (fr) 2004-05-12
WO2000016103A1 (fr) 2000-03-23
DE69917299D1 (de) 2004-06-17
FR2783326A1 (fr) 2000-03-17
JP2002525580A (ja) 2002-08-13
CA2342738A1 (fr) 2000-03-23
AU747648B2 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
DE69405251T2 (de) Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
DE69917051T2 (de) "flow-zytometrischer" vollblut- dendritzelle- immunfunctiontest
DE69131181T2 (de) Verfahren zum nachweis und zur quantifikation von zell-subsätzen innerhalb von subpopulationen einer vermischten zellpopulation
DE69622696T2 (de) Zellzählung durch einen immunoassay
DE3781610T2 (de) Diagnostikum fuer lyme-krankheit.
DE60033380T2 (de) Verfahren zur quantifizierung der zahl von leukozyten in einer blutprobe
DE3888779T2 (de) Immuntestsatz und -verfahren für ganze Zellen.
EP0407904A2 (de) Verfahren zur Bestimmung eines Analyten
DE69731982T2 (de) Verfahren zur messung der lymphozytenfunktion
DE69917299T2 (de) Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen
DE60208341T2 (de) Multidimensionale Analyse von Leukozyten
DE69628033T3 (de) Verfahren zur in vitro-analyse von toxischen und allergenen substanzen
Lorenz et al. Sensitive flow cytometric method to test basophil activation influenced by homeopathic histamine dilutions
EP0974050B1 (de) Basophilen-degranulationstest
DE60002466T2 (de) Quantifizierungsverfahren für endotheliale mikroteilchen
WO2009056283A1 (de) Verfahren zur in vitro-diagnose und/oder in vitro-therapieverfolgung von infektionen
DE602004007429T2 (de) Verfahren zur Zellselektion
DE10160921B4 (de) Verfahren zum Nachweis von Allergien und Verwendung eines Antikörpers zum Nachweis von Allergien
EP1179179B1 (de) Verwendung eines antikörpers zur detektion von basophilen und/oder mastzellen
DE10349162A1 (de) Schnelltest zur Diagnose der Alzheimerschen Erkrankung
DE19935047C2 (de) Multidimensionale Dynamische Cytofluorophorese (MDCFP)
EP2291658B1 (de) Durchflusszytometrisches verfahren zur bestimmung von gesamtleukozytenzahl und trombozytenzahl sowie zur leukozytendifferenzierung in blutproben von vögeln
DE19708877C1 (de) Antikörper 97A6
DE19945553B4 (de) Verfahren zum Nachweis von mindestens einer multiresistenten Keimart, insbesondere MRSA- und VRE-Keimen
US7300763B2 (en) Method of testing myelotoxicity with the use of flow cytometer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition